ACE-Inhibitors and ARBs in Heart Failure Therapy

Article

Video describes the importance and different uses of ACE-Inhibitors and ARBs in Heart Failure Therapy

Irina Sobol, MD, Assistant Professor of Medicine at the Perkin Heart Failure Center in the Cardiology Division of Weill Cornell Medical Center, discusses ACE-Inhibitors and ARBs in Heart Failure therapy.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Related Content
Pankaj Arora, MD | Credit: UAB

Pooled Cohort Equation Bests Life's Essential 8, Simple 7 for Predicting Long-Term CVD Risk

Patrick Campbell
July 24th 2024
Article
Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Kevin Kunzmann
July 22nd 2024
Podcast
Cardiovascular Disease Rates is Greater in Younger Than Older Adults with OsA

Cardiovascular Disease Rate is Greater in Younger Than Older Adults with OSA

Chelsie Derman
July 18th 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
Fernando Rodríguez-Artalejo, PhD | Credit: Mediterranean Diet and Health

Mediterranean Diet Linked to Improved Markers of Cardiometabolic Health in Children, Adolescents

Patrick Campbell
July 12th 2024
Article
Anxiety, Depression Interferes with Preventive Actions to Reduce CVD Risk Factors

Anxiety, Depression Interfere with Preventive Actions to Reduce CVD Risk Factors

Chelsie Derman
July 11th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.